Gert van der Hoek
In Memoriam - Editor, Senior Moderator
May 18, 2016
Food producers should label meat to reflect the quantity of antibiotics used in producing it. Pharmaceutical companies should receive a $1 billion windfall for developing a drug effective against particularly dangerous resistant pathogens. And a massive global campaign should be launched to make the world more aware of the dangers of antimicrobial resistance (AMR). These are just three conclusions from a widely anticipated report on how to tackle the spread of antimicrobial resistance, which was published today. Commissioned in 2014 by U.K. Prime Minister David Cameron and the Wellcome Trust, the report was led by economist Jim O’Neill, currently the Commercial Secretary to the Treasury in the United Kingdom.
Using antimicrobial drugs (not just antibiotics but also drugs against fungal, viral, or parasitic infections) invariably leads to the spread of pathogens that can tolerate them, and the problem is reaching crisis proportions, health experts widely agree. More and more pathogens are becoming resistant even to drugs seen as the last line of defense. Already, an estimated 700,000 people die every year from drug-resistant infections. (It’s important to note, however, that this estimate includes many who would have died even if their infection had been susceptible.) By 2050, drug-resistant infections could kill more people than cancer, according to the new report.
LINK TO FULL ARTICLE
Food producers should label meat to reflect the quantity of antibiotics used in producing it. Pharmaceutical companies should receive a $1 billion windfall for developing a drug effective against particularly dangerous resistant pathogens. And a massive global campaign should be launched to make the world more aware of the dangers of antimicrobial resistance (AMR). These are just three conclusions from a widely anticipated report on how to tackle the spread of antimicrobial resistance, which was published today. Commissioned in 2014 by U.K. Prime Minister David Cameron and the Wellcome Trust, the report was led by economist Jim O’Neill, currently the Commercial Secretary to the Treasury in the United Kingdom.
Using antimicrobial drugs (not just antibiotics but also drugs against fungal, viral, or parasitic infections) invariably leads to the spread of pathogens that can tolerate them, and the problem is reaching crisis proportions, health experts widely agree. More and more pathogens are becoming resistant even to drugs seen as the last line of defense. Already, an estimated 700,000 people die every year from drug-resistant infections. (It’s important to note, however, that this estimate includes many who would have died even if their infection had been susceptible.) By 2050, drug-resistant infections could kill more people than cancer, according to the new report.
The experts call for a two-tiered approach: Lower the use of available antimicrobials and increase the supply by stimulating the development of new ones. For instance, improved hygiene, faster and better diagnostics, and new vaccines could reduce unnecessary use of antibiotics. The authors also advocate a worldwide campaign to educate people about the dangers of resistance to keep patients from demanding antimicrobial drugs and doctors from prescribing them—an idea Laxminarayan endorses.
LINK TO FULL ARTICLE